What Historic and Forecast Market Sizes does the Imfinzi (durvalumab) Global Market Offer you?
The Imfinzi (durvalumab) market size has seen a rapid growth, expanding from $2,701.22 million in 2024 to $3,013.33 million in 2025, marking a compound annual growth rate (CAGR) of 11.6%. Factors such as expanded indications and approvals, increased demand for targeted therapies and immunotherapies, and improvements in immunotherapy have contributed to this growth in the historic period.
Further, it is projected that the market will continue to accelerate, expected to reach $4,143.36 million in 2029 at a CAGR of 11.3%. This forecasted growth can be attributed to the increased usage of combination therapies, burgeoning pharmaceutical R&D, escalating prevalence of cancer, growing acceptance of immunotherapy, rising regulatory footprint, and mounting investment in healthcare facilities. The forecast period is also expected to witness development trends such as adoption of personalized medicine techniques, focus on personalized medicine, adoption of biosimilars, integration of artificial intelligence and machine learning, and collaborations between pharmaceuticals.
Get Your Free Sample of The Global Imfinzi (durvalumab) Global Market Report 2025 Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=19906&type=smp
What Factors are Propelling the Growth of Imfinzi (durvalumab) Market?
The Imfinzi (durvalumab) market is poised for growth due to several factors. The primary one is the growing incidence of cancer. As the risk of cancer increases with age, and lifestyle factors such as smoking, poor diet, and obesity contribute to higher cancer rates, the demand for cancer treatment is rising. Imfinzi (durvalumab), which inhibits the PD-L1 protein, helps the immune system detect and eradicate cancer cells. The rise of personalized medicine, another key driver, provides treatment and healthcare strategies tailored to each patient’s unique characteristics. This promotes targeted therapies that improve patient outcomes while minimizing side effects. By enabling tailored immunotherapy treatments for cancer patients, Imfinzi (durvalumab) enhances treatment efficacy and minimizes unnecessary side effects.
What are the Major Segments in the Global Imfinzi (durvalumab) Market?
The Imfinzi (durvalumab) market is segmented into:
1) By Type: 2.4mL Injection; 10mL Injection
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Application: Locally Advanced Urothelial Carcinoma; Metastatic Urothelial Carcinoma; Other Applications
Order your report now for swift delivery: https://www.thebusinessresearchcompany.com/report/imfinzi-durvalumab-global-market-report
Who are the Key Players in the Imfinzi (durvalumab) Market?
Major companies operating in the imfinzi (durvalumab) market include AstraZeneca PLC.
What are the Emerging Trends in the Imfinzi (durvalumab) Market?
Focus on obtaining regulatory approvals to expand the utilization of Imfinzi for additional cancer types, enhance its clinical indications, and increase market reach represents a significant trend in the Imfinzi (durvalumab) market.
Which Region Holds the Largest Share in the Imfinzi (durvalumab) Market?
North America was the largest region in the Imfinzi (durvalumab) market in 2024. Additionally, Asia-Pacific is projected to be the fastest-growing region in the forecast period. The regions covered in the Imfinzi (durvalumab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does the Imfinzi (durvalumab) Global Market Report 2025 Offer?
Imfinzi (durvalumab) is a human monoclonal antibody and an immunotherapy drug designed to block programmed death-ligand 1 (PD-L1), a protein that tumors use to evade detection by the immune system. It is used to treat various cancers, including non-small cell lung cancer, small cell lung cancer, biliary tract cancer, and advanced urothelial carcinoma. The Imfinzi (durvalumab) Global Market Report 2025 research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19906
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead by contacting us via:
Europe : +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
